The Whole Day Matters After Stroke (BIG-STEPS)
Launched by UNIVERSITY OF ALBERTA · Feb 22, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The BIG-STEPS trial is a research study aimed at understanding how certain personal factors after a stroke can help tailor rehabilitation to improve recovery and mobility. Specifically, the study will test if reducing time spent sitting (sedentary behavior) in the early days after a stroke can enhance movement and overall disability outcomes. Researchers will also look at brain imaging results to see how they might affect recovery and will use activity trackers to gather data on participants' movement patterns.
To participate in this study, individuals must be at least 18 years old, have experienced an ischemic stroke within the last week, and be medically stable. They should be able to walk at least 5 meters, with or without assistance, and have ongoing goals related to walking. Participants can expect to undergo various assessments related to their mobility and overall health, wear an activity tracker for a week, and take part in a six-week program aimed at reducing sedentary behavior. Follow-up assessments will be done at 90 days to evaluate progress. This trial is currently recruiting participants of all genders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Within 7 days of ischemic stroke onset
- • Aged ≥ 18 years
- • Medically stable as deemed by physicians
- • Able to walk at least 5 meters with/without gait aid
- • Ongoing walking goals (walk speed \<1.0 meter/sec)
- Exclusion Criteria:
- • Have another condition such as multiple sclerosis or Parkinson's disease, or active cancer
- • Uncontrolled high blood pressure
- • Unstable cardiovascular condition
- • Unable to understand or follow instructions.
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Victor Ezeugwu, PhD
Principal Investigator
University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials